Preparing for a New Era in Chronic Cough Management: Managed Care Considerations on the Role of New and Emerging Therapies
is a two-part webinar series

A continuing medical education activity sponsored by NAMCP and AAMCN

This webinar series will review the burden of chronic cough, discuss the current recommendations for the
management of patients with chronic cough, and evaluate the latest clinical data regarding emerging
pharmacotherapies for the treatment of patients with refractory chronic cough

These are archives of live webinars held between May 5, 2021 to May 11, 2021
If you participated in any of the live webinars, you are not eligible to claim
credit from the archive of that webinar.

This activity is valid from June 1, 2021 to June 1, 2023


This series is supported by an educational grant from
Merck Sharp & Dohme Corp.


 
Audience: This activity is intended for healthcare professionals practicing in managed care environments.

Instructions for CME/NCPD: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

Description:
Chronic cough, which is observed in approximately 12% of the US population, is defined as a cough that lasts for more than 8 weeks. Patients with chronic cough are often distressed by the condition, which can lead to depression, anxiety, a decline in quality of life, and changes to their social activities. The diagnosis and management of chronic cough can be challenging, with only approximately 50% of patients receiving a diagnosis. Recent advances have been made in the understanding and management of refractory chronic cough, with several novel therapies being evaluated in ongoing clinical studies.


Preparing for a New Era in Chronic Cough Management: Managed Care Considerations on the Role of New and Emerging Therapies

  1. Determine the etiology of chronic cough, along with the burden and the pathophysiology
  2. Investigate the treatment of chronic cough, including emerging therapies
  3. Examine treatment plans for patients with chronic cough that targets the type of cough and minimizes adverse effects about new treatments and their mechanisms of action
  4. Review managed care considerations of emerging P2X3 receptor antagonists in the management of chronic cough
       Physician, Nursing and CMCN credits valid to June 1, 2023

Preparing for a New Era in Chronic Cough Management: A Closer Look at the Role of New and Emerging Therapies

  1. Review current unmet needs for patients with chronic cough and the burden on patient quality of life
  2. Analyze mechanisms underlying chronic cough and the implications for treatment
  3. Assess the latest clinical evidence regarding emerging treatment strategies for patients with chronic cough
  4. Examine the role of emerging P2X3 receptor antagonists in the management of chronic cough
       Physician, Nursing and CMCN credits valid to June 1, 2023